Benefits and side effects of blood pressure lowering treatment: What was wrong with doxazosin in the ALLHAT?

Current Controlled Trials in Cardiovascular Medicine

Volumn 2, Issue 6, 2001, Pages 257-259

  Gavras, Irene ^a   Gavras, Haralambos ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; AMLODIPINE; ANTIHYPERTENSIVE AGENT; ANTIOXIDANT; ARGIPRESSIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CHLORTALIDONE; DIHYDROPYRIDINE DERIVATIVE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; DOXAZOSIN; ESTROGEN; LISINOPRIL; PLACEBO; TERAZOSIN; THIAZIDE DIURETIC AGENT;

CARDIOVASCULAR RISK; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; HEART FAILURE; HEART INFARCTION; HIGH RISK PATIENT; HUMAN; HYPERTENSION; KIDNEY FAILURE; MONOTHERAPY; MORBIDITY; MORTALITY; NOTE; PROSTATE HYPERTROPHY; RANDOMIZED CONTROLLED TRIAL; RISK BENEFIT ANALYSIS; SIDE EFFECT; STROKE; SYSTOLIC BLOOD PRESSURE;

EID: 0035703246     PISSN: 14686708     EISSN: None     Source Type: Journal    
DOI: 10.1186/CVM-2-6-257     Document Type: Note

References (21)

1. 1999 World Health Organization-International Society of Hypertension Guidelines for the management of hypertension. Guidelines sub-committee of the World Health Organization
2. Insulin resistance, glucose intolerance and hyperinsulinemia in patients with hypertension
3. Hypertension and antihypertensive therapy as risk factors for type 2 diabetes mellitus. Atherosclerosis Risk in Communities Study
4. Effect of antihypertensive drugs on insulin, glucose, and lipid metabolism
5. Coronary heart disease in women - An ounce of prevention
6. Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: Results of prospectively designed overviews of randomised trials. Blood Pressure Lowering Treatment Trialists. Collaboration
7. Rationale and design for the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). ALLHAT Research Group
8. Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone; the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT)
9. Pressor systems in hypertension and congestive heart failure: Role of vasopressin
10. Interaction of vasopressin and the baroreceptor reflex system in the regulation of arterial blood pressure in the dog
11. Effects of vasopressin on the circulation and its baroreflex control in healthy men
12. Sequential elimination of pressor mechanisms in severe hypertension in humans
13. The adrenergic system and the release and pressor action of vasopressin
14. Contribution of vasopressin to vasoconstriction in patients with congestive heart failure: Comparison of vasopressin to the renin-angiotensin system and the sympathetic nervous system
15. Pressor effect of arginine vasopressin in progressive autonomic failure
16. Age and race determine vasopressin participation in upright blood pressure control in essential hypertension
17. Cardiac accidents following vasopressin injection (pitressin)
18. Pitressin-induced myocardial injury and depression in a young woman
19. Vasopressin provocation of ventricular dysrhythmia
20. Effect of arginine vasopressin on coronary and systemic hemodynamics in man
21. Role of vasopressin in cardiovascular regulation